Is Charlotte’s Web (TSX:CWEB) a Better Buy Than Aurora Cannabis (TSX:ACB)?

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) has long been one of the top two stocks in the cannabis industry, but that might not be the case for much longer.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Competition in the cannabis industry is growing, and it’s getting even harder for industry leaders like Aurora Cannabis (TSX:ACB)(NYSE:ACB) to hold their positions. With a market cap of around $10 billion, Aurora is definitely one of the highest-valued stocks in the markets, but whether it will stay that way is the big question.

Let’s take a close look with how the company compares against Charlotte’s Web Holdings (TSX:CWEB), which recently listed on the TSX.

Recent performance

Aurora is coming off a Q3 where its sales reached $65 million, which was still short of expectations. For the trailing 12 months, the company’s revenues are now at around $168 million, which is significant growth considering sales for fiscal 2018 were just $55 million and $18 million the year before that. However, it’s been the bottom line that has been the issue, with Aurora incurring net losses of $211 million over the past four quarters. And with lots of expansion on the way, it could get a lot worse before it gets better.

In its most recent quarter, Charlotte’s Web posted sales of US$22 million, putting its total for the last four periods at US$78 million, or about $104 million after conversion. It’s well off of Aurora’s pace, but a key difference is that Charlotte’s Web has been able to post profits in each of its past four quarters. While they haven’t been particularly large, the company has even been able to post a positive operating income figure as well.

Strategy and overall potential

The two companies are deploying vastly different strategies from one another. Aurora is focusing on the global market with a presence in dozens of countries, with Canada playing a big role in that. While the company is looking to deploy a hemp strategy for the U.S., it’s going to be well behind Charlotte’s Web, a company that’s already dominating that space. With its products already in thousands of locations across the country, Charlotte’s Web’s strategy has focused on hemp, and it’s proven to be a very strong one thus far.

Overall, Charlotte’s Web certainly has the edge here. Not only has it generated strong growth, but it’s more focused than Aurora’s and has been profitable as well.

Valuation

Although Charlotte’s Web has had fewer sales than Aurora, it trades at around 21 times its revenues, which is far less than the multiple of 61 that Aurora’s stock trades at. In terms of valuation, it’s clear that Charlotte’s Web provides investors much better value for their money today.

Bottom line

Aurora may be ahead of Charlotte’s Web based on sales, but that could change a year from now, as hemp has been taking off in the U.S. and could lead to even more growth in that segment. And with a more sustainable business model that’s provided stronger financials, it’s hard not to give Charlotte’s Web the edge, especially with its valuation being much more attractive overall.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »